These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


488 related items for PubMed ID: 30727773

  • 1. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
    Yang J, Tang A, Ma J, Sun X, Ming L.
    Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
    [Abstract] [Full Text] [Related]

  • 2. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
    Hui L, Rixv L, Xiuying Z.
    Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
    [Abstract] [Full Text] [Related]

  • 3. A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in southwestern China using real-world data.
    Miao Q, Lei S, Chen F, Niu Q, Luo H, Cai B.
    BMC Cancer; 2024 May 29; 24(1):657. PubMed ID: 38811867
    [Abstract] [Full Text] [Related]

  • 4. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
    Bjerner J, Høgetveit A, Wold Akselberg K, Vangsnes K, Paus E, Bjøro T, Børmer OP, Nustad K.
    Scand J Clin Lab Invest; 2008 May 29; 68(8):703-13. PubMed ID: 18609108
    [Abstract] [Full Text] [Related]

  • 5. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer.
    Zhong W, Yu Z, Zhan J, Yu T, Lin Y, Xia ZS, Yuan YH, Chen QK.
    Pathol Oncol Res; 2015 Jan 29; 21(1):83-95. PubMed ID: 24875250
    [Abstract] [Full Text] [Related]

  • 6. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer.
    Chen ZQ, Huang LS, Zhu B.
    Dis Markers; 2018 Jan 29; 2018():9845123. PubMed ID: 30647803
    [Abstract] [Full Text] [Related]

  • 7. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS, Cheng BC, Ge W, Gao JF.
    Int J Clin Pract; 2007 Mar 29; 61(3):444-8. PubMed ID: 17313612
    [Abstract] [Full Text] [Related]

  • 8. Serum tumour markers in patients with chronic kidney disease.
    Xiaofang Y, Yue Z, Xialian X, Zhibin Y.
    Scand J Clin Lab Invest; 2007 Mar 29; 67(6):661-7. PubMed ID: 17852811
    [Abstract] [Full Text] [Related]

  • 9. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S, Shen L, Qian N, Chen K.
    Cancer Biomark; 2007 Mar 29; 10(3-4):155-62. PubMed ID: 22674301
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
    Gao Y, Wang J, Zhou Y, Sheng S, Qian SY, Huo X.
    Sci Rep; 2018 Feb 09; 8(1):2732. PubMed ID: 29426902
    [Abstract] [Full Text] [Related]

  • 11. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
    Wang WJ, Tao Z, Gu W, Sun LH.
    Asian Pac J Cancer Prev; 2013 Feb 09; 14(7):4369-71. PubMed ID: 23992005
    [Abstract] [Full Text] [Related]

  • 12. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
    Chen C, Chen Q, Zhao Q, Liu M, Guo J.
    Ann Clin Lab Sci; 2017 May 09; 47(3):260-263. PubMed ID: 28667025
    [Abstract] [Full Text] [Related]

  • 13. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX, Wang Y, Xu XQ, Sun T, Tian BG, Du LL, Zhao XW, Han CZ.
    Asian Pac J Cancer Prev; 2014 May 09; 15(23):10267-72. PubMed ID: 25556459
    [Abstract] [Full Text] [Related]

  • 14. Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.
    Yang-Chun F, Min F, Di Z, Yan-Chun H.
    Medicine (Baltimore); 2016 May 09; 95(18):e3568. PubMed ID: 27149479
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L, Zhang Y, Chen M, Chen J.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep 25; 20(9):1002-1008. PubMed ID: 28900990
    [Abstract] [Full Text] [Related]

  • 16. [Clinical Significance of Tumor Marker Detection in Patients 
with Advanced Squamous Cell Carcimoma of the Lung].
    Liang P, Li J.
    Zhongguo Fei Ai Za Zhi; 2016 Oct 20; 19(10):641-647. PubMed ID: 27760591
    [Abstract] [Full Text] [Related]

  • 17. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W, Xu X, Tian B, Wang Y, Du L, Sun T, Shi Y, Zhao X, Jing J.
    Clin Chim Acta; 2017 Jul 20; 470():51-55. PubMed ID: 28457854
    [Abstract] [Full Text] [Related]

  • 18. Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?
    Szekanecz E, Sándor Z, Antal-Szalmás P, Soós L, Lakos G, Besenyei T, Szentpétery A, Simkovics E, Szántó J, Kiss E, Koch AE, Szekanecz Z.
    Ann N Y Acad Sci; 2007 Jun 20; 1108():359-71. PubMed ID: 17893999
    [Abstract] [Full Text] [Related]

  • 19. The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control.
    Shang X, Song C, Du X, Shao H, Xu D, Wang X.
    Saudi Med J; 2017 Feb 20; 38(2):204-208. PubMed ID: 28133696
    [Abstract] [Full Text] [Related]

  • 20. [The determination of medical reference values for tumor markers in cerebrospinal fluid].
    Shi Q, Pu CQ, Wu WP, Huang XS, Yu SY, Tian CL, Cao XT.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 10; 89(5):355-6. PubMed ID: 19563718
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.